2型糖尿病心血管风险预测:基层医疗环境中22种风险评分的比较
在168,871例英国2型糖尿病患者中比较22种心血管疾病风险预测评分,所有模型区分能力均有限且相近,SCORE CVD规则表现最佳(C统计量0.67-0.69),简单重新校准可显著改善校准,但区分度仍 modest,糖尿病专用评分未优于一般人群评分。
要点
- 在168,871例英国2型糖尿病患者中,22种CVD风险评分的区分能力均有限且相近。
- SCORE CVD规则在CVD(C统计量0.67)和CVD+(C统计量0.69)中表现最佳。
- 简单重新校准可大幅改善校准斜率,但区分度提升有限。
核心结论
- 所有22种评估模型在10年随访中均不能准确识别发生CVD事件的2型糖尿病患者,区分能力相近且有限。
研究设计与样本
- 通过文献综述识别风险评分,纳入时不限预测心血管结局类型或是否包含2型糖尿病患者。
- 在168,871例英国2型糖尿病患者(年龄≥18岁,无既往CVD+)的当代代表性样本中评估性能,缺失观察值采用多重插补处理。
主要发现
- 共评估22种评分:13种源于一般人群,9种源于2型糖尿病人群。
- SCORE CVD规则对CVD的C统计量为0.67(95%CI 0.67, 0.67),对CVD+的C统计量为0.69(95%CI 0.69, 0.70)。
- 其余评分的C统计量对CVD为0.62至0.67,对CVD+为0.64至0.69。
- 校准斜率(1表示完美校准)对CVD为0.38(95%CI 0.37, 0.39)至0.74(95%CI 0.72, 0.76),对CVD+为0.41(95%CI 0.40, 0.42)至0.88(95%CI 0.86, 0.90)。
- 简单重新校准后校准斜率对CVD为0.96至1.04;QRISK3(19个变量)对CVD+的C统计量为0.68(95%CI 0.68, 0.69),SCORE CVD(6个变量)为0.69(95%CI 0.69, 0.70);UKPDS评分显著劣于SCORE CVD(p值<0.001)。
关键数值与推荐
- SCORE CVD规则对CVD的C统计量为0.67(95%CI 0.67, 0.67),对CVD+的C统计量为0.69(95%CI 0.69, 0.70)。
- 其余评分对CVD的C统计量范围为0.62至0.67,对CVD+为0.64至0.69。
- 校准斜率对CVD范围为0.38(95%CI 0.37, 0.39)至0.74(95%CI 0.72, 0.76),对CVD+范围为0.41(95%CI 0.40, 0.42)至0.88(95%CI 0.86, 0.90)。
- 简单重新校准后对CVD的校准斜率范围为0.96至1.04。
- QRISK3对CVD+的C统计量为0.68(95%CI 0.68, 0.69),SCORE CVD为0.69(95%CI 0.69, 0.70);UKPDS评分显著劣于SCORE CVD(p值<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to compare the performance of risk prediction scores for CVD (i.e., coronary heart disease and stroke), and a broader definition of CVD including atrial fibrillation and heart failure (CVD+), in individuals with type 2 diabetes. METHODS: Scores were identified through a literature review and were included irrespective of the type of predicted cardiovascular outcome or the inclusion of individuals with type 2 diabetes. Performance was assessed in a contemporary, representative sample of 168,871 UK-based individuals with type 2 diabetes (age ≥18 years without pre-existing CVD+). Missing observations were addressed using multiple imputation. RESULTS: We evaluated 22 scores: 13 derived in the general population and nine in individuals with type 2 diabetes. The Systemic Coronary Risk Evaluation (SCORE) CVD rule derived in the general population performed best for both CVD (C statistic 0.67 [95% CI 0.67, 0.67]) and CVD+ (C statistic 0.69 [95% CI 0.69, 0.70]). The C statistic of the remaining scores ranged from 0.62 to 0.67 for CVD, and from 0.64 to 0.69 for CVD+. Calibration slopes (1 indicates perfect calibration) ranged from 0.38 (95% CI 0.37, 0.39) to 0.74 (95% CI 0.72, 0.76) for CVD, and from 0.41 (95% CI 0.40, 0.42) to 0.88 (95% CI 0.86, 0.90) for CVD+. A simple recalibration process considerably improved the performance of the scores, with calibration slopes now ranging between 0.96 and 1.04 for CVD. Scores with more predictors did not outperform scores with fewer predictors: for CVD+, QRISK3 (19 variables) had a C statistic of 0.68 (95% CI 0.68, 0.69), compared with SCORE CVD (six variables) which had a C statistic of 0.69 (95% CI 0.69, 0.70). Scores specific to individuals with diabetes did not discriminate better than scores derived in the general population: the UK Prospective Diabetes Study (UKPDS) scores performed significantly worse than SCORE CVD (p value <0.001). CONCLUSIONS/INTERPRETATION: CVD risk prediction scores could not accurately identify individuals with type 2 diabetes who experienced a CVD event in the 10 years of follow-up. All 22 evaluated models had a comparable and modest discriminative ability.
引用
- Dziopa K, Asselbergs FW, Gratton J, et al. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings. Diabetologia. 2022. PMID: 35032176. doi:10.1007/s00125-021-05640-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。